#insurance coverage

Stopping GLP-1s May Trigger Weight Regain and Heart Risk

Reports suggest discontinuing GLP-1 medications (like semaglutide/tirzepatide) often leads to meaningful weight regain and may worsen cardiometabolic risk facto...